Kinesigenic dyskinesias after ENT surgery misdiagnosed as focal epilepsy.
epilepsy and seizures
movement disorders (other than Parkinson's)
neurological injury
neurology
neurology (drugs and medicines)
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
29 Mar 2022
29 Mar 2022
Historique:
pmc-release:
29
03
2024
entrez:
30
3
2022
pubmed:
31
3
2022
medline:
1
4
2022
Statut:
epublish
Résumé
We describe a man in his 30s who presented with paroxysmal right-sided dyskinesias of the arm and neck, misdiagnosed with drug-resistant focal epilepsy. Two months earlier he had undergone surgery for chronic sinusitis. Immediately after this procedure, he developed hemiparesis, hemiataxia, paresthesias and disturbances in verbal fluency. Cranial MRI revealed a disruption of the left lamina cribrosa and an intracerebral injury resembling a branch canal spanning to the left dorsal third of the thalamus. Single-photon emission tomography imaging demonstrated malperfusion of the left ventral thalamus, left-sided cortex and right cerebellar hemisphere. During continuous video-EEG monitoring, three dyskinetic episodes with tremor of the right arm and dystonia of the finger and shoulder could be recorded. The paroxysmal dyskinesias did not improve with carbamazepine, valproate and tiapride. This case demonstrates an unusual symptomatic cause of a thalamic movement disorder misdiagnosed as focal epilepsy and highlights the postoperative complications, diagnostic and treatment efforts.
Identifiants
pubmed: 35351750
pii: 15/3/e247760
doi: 10.1136/bcr-2021-247760
pmc: PMC8966546
pii:
doi:
Substances chimiques
Carbamazepine
33CM23913M
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: EK and SDT have no conflict of interest. SN reports personal fees from Desitin, UCB Pharma, Medtronic, Eisai and Zogenix.